Cargando…
Preoperative Metabolic Tumor Volume2.5 Associated with Early Systemic Metastasis in Resected Pancreatic Cancer: A Transcriptome-Wide Analysis
BACKGROUND/AIMS: (18)F-fluorodeoxyglucose-positron emission tomography ((18)F-FDG-PET) reflects biological aggressiveness and predicts prognoses in various tumors. Evaluating the oncologic significance of the preoperative metabolic phenotype might be necessary for planning the surgical strategy in r...
Autores principales: | Lee, Sung Hwan, Hwang, Ho Kyoung, Lee, Woo Jung, Yun, Mijin, Kang, Chang Moo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529162/ https://www.ncbi.nlm.nih.gov/pubmed/30602217 http://dx.doi.org/10.5009/gnl18242 |
Ejemplares similares
-
Preoperative Volume-Based PET Parameter, MTV(2.5), as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer
por: Kang, Chang Moo, et al.
Publicado: (2016) -
Clinically determined type of (18)F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer
por: Chong, Jae Uk, et al.
Publicado: (2017) -
Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
por: Yoon, Ja Kyung, et al.
Publicado: (2022) -
Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinoma
por: Rho, Seoung Yoon, et al.
Publicado: (2019) -
Maximum Standard Uptake Value as a Clinical Biomarker for Detecting Loss of SMAD4 Expression and Early Systemic Tumor Recurrence in Resected Left-Sided Pancreatic Cancer
por: Kang, Chang Moo, et al.
Publicado: (2016)